The global isothermal nucleic acid amplification technology (INAAT) market is expected to reach USD 4.3 billion by 2025, growing at a CAGR of 11.8%, according to a new report by Grand View Research, Inc. This can be attributed to significant rise in awareness regarding need for rapid and on-time testing for chronic and infectious diseases. Global increase in adoption of INAAT for detection of HIV, hepatitis A & B, and sexually transmitted diseases is considered to be a high impact rendering driver for growth.
Loop-Mediated Isothermal Amplification is one of the most preferred nucleic acid amplification methods because of its ability to provide point of care testing, thus leading to increased adoption. The recently-introduced Nicking Enzyme Amplification Reaction (NEAR) and Helicase-dependent amplification (HDA) technologies are expected to experience exponential growth during the forecast period owing to their patent protection.
In addition, owing to recent epidemics of infectious diseases, such as tuberculosis, Zika virus, and influenza, importance of point of care diagnosis has increased especially in developing countries. This is also anticipated to boost demand for this technology in these regions.
To request a sample copy or view summary of this report, click the link below:
Further Key Findings From the Report Suggest:
Reagents are expected to be fastest growing products owing to their high usage in all INAAT procedures
TMA was identified as the largest technology segment by revenue share in 2016 owing to its high adoption
Infectious disease diagnostics is expected to be the fastest growing application owing to development of numerous assays for detection of specific infectious diseases
Hospitals dominated the end user segment in 2016 with the largest share and are expected to be continue dominance over the forecast period owing to the high usage of INAAT in hospitals globally
North America held the largest share of the global market in 2016, and the U.S. held the largest revenue share in the region owing to rise in infectious diseases, availability of government funds, prevalence of cancer, application of MDx in cancer screening & genetic disorders, and self-monitoring techniques
The molecular diagnostics industry in Asia Pacific is projected to witness substantial growth over the next decade due to various developments in major economies, especially in the NASBA, NEAR, and HDA technology segments
Some of the key players in the INAAT market include Alere; bioMerieux SA; Eiken Chemical Co. Ltd.; Hologic, Inc. (Gen-Probe); Lucigen; QIAGEN; Quidel Corporation; ThermoFisher Scientific; and Becton, Dickinson & Company
Major players have been engaging in numerous strategic initiatives such as mergers and acquisitions to increase global presence and improve market share.
Grand View Research has segmented the global INAAT market on the basis of product, technology, application, end-use, and region:
Isothermal Nucleic Acid Amplification By Product Outlook (Revenue, USD Million, 2014 - 2025)
Isothermal Nucleic Acid Amplification By Technology Outlook (Revenue, USD Million, 2014 - 2025)
Isothermal Nucleic Acid Amplification By Application Outlook (Revenue, USD Million, 2014 - 2025)
Infectious disease diagnostics
Isothermal Nucleic Acid Amplification By End Use Outlook (Revenue, USD Million, 2014 - 2025)
Central and reference labs
Regional Outlook (Revenue, USD Million, 2014 - 2025)
Central & South America
Middle East & Africa
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.